Renato Chirivi, Ph.D. Head Internal Therapeutic development and Helmuth van Es, Ph.D. CEO of Citryll will be attending the annual meeting of the American College for Rheumatology in San Francisco.
The conference will be held from 8-11 November at the Moscone Center in San Francisco.
We will be presenting the tACPA programme and its NETosis MOA on Sunday November 8, Citryll presentation tACPA.
An ideal opportunity to meet us and discuss possibilities to collaborate, partner with or invest in Citryll’s programme.
If you are interested in our innovative approach to autoimmune diseases and the potential to leverage inhibiting NET function, please do contact us for setting up a meeting during the ACR. This can be done through the Collaborating with Citryll page.